Cargando…

Genome-wide DNA methylation profile identified a unique set of differentially methylated immune genes in oral squamous cell carcinoma patients in India

BACKGROUND: Oral squamous cell carcinoma (OSCC) is one of the common malignancies in Southeast Asia. Epigenetic changes, mainly the altered DNA methylation, have been implicated in many cancers. Considering the varied environmental and genotoxic exposures among the Indian population, we conducted a...

Descripción completa

Detalles Bibliográficos
Autores principales: Basu, Baidehi, Chakraborty, Joyeeta, Chandra, Aditi, Katarkar, Atul, Baldevbhai, Jadav Ritesh Kumar, Dhar Chowdhury, Debjit, Ray, Jay Gopal, Chaudhuri, Keya, Chatterjee, Raghunath
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5292006/
https://www.ncbi.nlm.nih.gov/pubmed/28174608
http://dx.doi.org/10.1186/s13148-017-0314-x
_version_ 1782504864763346944
author Basu, Baidehi
Chakraborty, Joyeeta
Chandra, Aditi
Katarkar, Atul
Baldevbhai, Jadav Ritesh Kumar
Dhar Chowdhury, Debjit
Ray, Jay Gopal
Chaudhuri, Keya
Chatterjee, Raghunath
author_facet Basu, Baidehi
Chakraborty, Joyeeta
Chandra, Aditi
Katarkar, Atul
Baldevbhai, Jadav Ritesh Kumar
Dhar Chowdhury, Debjit
Ray, Jay Gopal
Chaudhuri, Keya
Chatterjee, Raghunath
author_sort Basu, Baidehi
collection PubMed
description BACKGROUND: Oral squamous cell carcinoma (OSCC) is one of the common malignancies in Southeast Asia. Epigenetic changes, mainly the altered DNA methylation, have been implicated in many cancers. Considering the varied environmental and genotoxic exposures among the Indian population, we conducted a genome-wide DNA methylation study on paired tumor and adjacent normal tissues of ten well-differentiated OSCC patients and validated in an additional 53 well-differentiated OSCC and adjacent normal samples. RESULTS: Genome-wide DNA methylation analysis identified several novel differentially methylated regions associated with OSCC. Hypermethylation is primarily enriched in the CpG-rich regions, while hypomethylation is mainly in the open sea. Distinct epigenetic drifts for hypo- and hypermethylation across CpG islands suggested independent mechanisms of hypo- and hypermethylation in OSCC development. Aberrant DNA methylation in the promoter regions are concomitant with gene expression. Hypomethylation of immune genes reflect the lymphocyte infiltration into the tumor microenvironment. Comparison of methylome data with 312 TCGA HNSCC samples identified a unique set of hypomethylated promoters among the OSCC patients in India. Pathway analysis of unique hypomethylated promoters indicated that the OSCC patients in India induce an anti-tumor T cell response, with mobilization of T lymphocytes in the neoplastic environment. Survival analysis of these epigenetically regulated immune genes suggested their prominent role in OSCC progression. CONCLUSIONS: Our study identified a unique set of hypomethylated regions, enriched in the promoters of immune response genes, and indicated the presence of a strong immune component in the tumor microenvironment. These methylation changes may serve as potential molecular markers to define risk and to monitor the prognosis of OSCC patients in India. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s13148-017-0314-x) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-5292006
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-52920062017-02-07 Genome-wide DNA methylation profile identified a unique set of differentially methylated immune genes in oral squamous cell carcinoma patients in India Basu, Baidehi Chakraborty, Joyeeta Chandra, Aditi Katarkar, Atul Baldevbhai, Jadav Ritesh Kumar Dhar Chowdhury, Debjit Ray, Jay Gopal Chaudhuri, Keya Chatterjee, Raghunath Clin Epigenetics Research BACKGROUND: Oral squamous cell carcinoma (OSCC) is one of the common malignancies in Southeast Asia. Epigenetic changes, mainly the altered DNA methylation, have been implicated in many cancers. Considering the varied environmental and genotoxic exposures among the Indian population, we conducted a genome-wide DNA methylation study on paired tumor and adjacent normal tissues of ten well-differentiated OSCC patients and validated in an additional 53 well-differentiated OSCC and adjacent normal samples. RESULTS: Genome-wide DNA methylation analysis identified several novel differentially methylated regions associated with OSCC. Hypermethylation is primarily enriched in the CpG-rich regions, while hypomethylation is mainly in the open sea. Distinct epigenetic drifts for hypo- and hypermethylation across CpG islands suggested independent mechanisms of hypo- and hypermethylation in OSCC development. Aberrant DNA methylation in the promoter regions are concomitant with gene expression. Hypomethylation of immune genes reflect the lymphocyte infiltration into the tumor microenvironment. Comparison of methylome data with 312 TCGA HNSCC samples identified a unique set of hypomethylated promoters among the OSCC patients in India. Pathway analysis of unique hypomethylated promoters indicated that the OSCC patients in India induce an anti-tumor T cell response, with mobilization of T lymphocytes in the neoplastic environment. Survival analysis of these epigenetically regulated immune genes suggested their prominent role in OSCC progression. CONCLUSIONS: Our study identified a unique set of hypomethylated regions, enriched in the promoters of immune response genes, and indicated the presence of a strong immune component in the tumor microenvironment. These methylation changes may serve as potential molecular markers to define risk and to monitor the prognosis of OSCC patients in India. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s13148-017-0314-x) contains supplementary material, which is available to authorized users. BioMed Central 2017-02-03 /pmc/articles/PMC5292006/ /pubmed/28174608 http://dx.doi.org/10.1186/s13148-017-0314-x Text en © The Author(s). 2017 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Basu, Baidehi
Chakraborty, Joyeeta
Chandra, Aditi
Katarkar, Atul
Baldevbhai, Jadav Ritesh Kumar
Dhar Chowdhury, Debjit
Ray, Jay Gopal
Chaudhuri, Keya
Chatterjee, Raghunath
Genome-wide DNA methylation profile identified a unique set of differentially methylated immune genes in oral squamous cell carcinoma patients in India
title Genome-wide DNA methylation profile identified a unique set of differentially methylated immune genes in oral squamous cell carcinoma patients in India
title_full Genome-wide DNA methylation profile identified a unique set of differentially methylated immune genes in oral squamous cell carcinoma patients in India
title_fullStr Genome-wide DNA methylation profile identified a unique set of differentially methylated immune genes in oral squamous cell carcinoma patients in India
title_full_unstemmed Genome-wide DNA methylation profile identified a unique set of differentially methylated immune genes in oral squamous cell carcinoma patients in India
title_short Genome-wide DNA methylation profile identified a unique set of differentially methylated immune genes in oral squamous cell carcinoma patients in India
title_sort genome-wide dna methylation profile identified a unique set of differentially methylated immune genes in oral squamous cell carcinoma patients in india
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5292006/
https://www.ncbi.nlm.nih.gov/pubmed/28174608
http://dx.doi.org/10.1186/s13148-017-0314-x
work_keys_str_mv AT basubaidehi genomewidednamethylationprofileidentifiedauniquesetofdifferentiallymethylatedimmunegenesinoralsquamouscellcarcinomapatientsinindia
AT chakrabortyjoyeeta genomewidednamethylationprofileidentifiedauniquesetofdifferentiallymethylatedimmunegenesinoralsquamouscellcarcinomapatientsinindia
AT chandraaditi genomewidednamethylationprofileidentifiedauniquesetofdifferentiallymethylatedimmunegenesinoralsquamouscellcarcinomapatientsinindia
AT katarkaratul genomewidednamethylationprofileidentifiedauniquesetofdifferentiallymethylatedimmunegenesinoralsquamouscellcarcinomapatientsinindia
AT baldevbhaijadavriteshkumar genomewidednamethylationprofileidentifiedauniquesetofdifferentiallymethylatedimmunegenesinoralsquamouscellcarcinomapatientsinindia
AT dharchowdhurydebjit genomewidednamethylationprofileidentifiedauniquesetofdifferentiallymethylatedimmunegenesinoralsquamouscellcarcinomapatientsinindia
AT rayjaygopal genomewidednamethylationprofileidentifiedauniquesetofdifferentiallymethylatedimmunegenesinoralsquamouscellcarcinomapatientsinindia
AT chaudhurikeya genomewidednamethylationprofileidentifiedauniquesetofdifferentiallymethylatedimmunegenesinoralsquamouscellcarcinomapatientsinindia
AT chatterjeeraghunath genomewidednamethylationprofileidentifiedauniquesetofdifferentiallymethylatedimmunegenesinoralsquamouscellcarcinomapatientsinindia